
手機(jī)掃碼訪問本站

微信咨詢
猜你喜歡
- 5-(4-(2-(5-(1-(MethoxyMethoxy)ethyl)pyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione
- 5-(3-Chloropropyl)-10,11-dihydro-2-hydroxy-5H-dibenz[b,f]azepine
- Methyl 2,3,4-Triacetyl-D-glucopyranosiduronyl 1-(N-4-Metoxyphenyl)-2,2,2-trifluoroacetimidate
- 2-甲基-3-(吡咯烷基-1-基)丙-1-醇
- 6-(氯甲基)脲嘧啶
- 443913-73-3 / FDA批準(zhǔn)Vandetanib(中文名:凡德他尼)為首個(gè)治療甲狀腺髓樣癌藥物
- 二[二(三甲基甲硅烷基)氨基]錫(II)
- 1,1,2,2-四氫全氟己基碘
- 5-(1,3-DIOXOLAN-2-YL)-2-(2-IODOBENZOYL)THIOPHENE
- 4-甲基-1(2H)-二氮雜萘酮
- 12054-85-2/鉬酸銨的用途
- 5-氯-2-(乙胺基)苯胺
- (4-CHLOROBENZYL)-(1-PHENYLETHYL)AMINE
- 2,4-二甲氧基苯甲胺
- 2-(4-氯-3-硝基苯甲酰)苯甲酸
- 6-溴-2-(2-異丙氧芬基)-喹啉-4-羧酸
- 3,6-二甲基-1-庚炔-3-醇
- 4-CHLORO-6,7-DIFLUORO-QUINOLINE-3-CARBONITRILE
- 112539-09-0/4-(2-氧-1-吡咯啉基)苯磺酰氯的制備方法
- 2,2-二溴-丙二酰胺
- 1,4-diaMinocyclohexane-1-carboxylic acid
- N-Desethyl Sunitinib Malate
- 2-氰基-4,4-二乙氧基丁酸乙酯
- 532-32-1/苯甲酸鈉對(duì)人體的危害
- 4-(環(huán)辛氨基)-4-氧代-丁酸